BRIEF published on 11/06/2024 at 08:05, 15 days 5 hours ago PUMA Reports Accelerated Sales Growth in Q3 2024 Direct-to-consumer Growth 2024 Financial Outlook Q3 Financial Results Currency Impact PUMA Sales Growth
PRESS RELEASE published on 11/06/2024 at 08:00, 15 days 5 hours ago PUMA’s sales growth accelerates in Q3 and EBIT in line with expectations PUMA's sales growth accelerates in Q3 with EBIT meeting expectations. Currency-adjusted sales up 5.0% driven by all regions Sales Growth EBIT PUMA Q3 Currency-adjusted
BRIEF published on 09/26/2024 at 10:05, 1 month 25 days ago PUMA Appoints Markus Neubrand as Chief Financial Officer Chief Financial Officer Management Board PUMA Personnel Change Markus Neubrand
PRESS RELEASE published on 09/26/2024 at 10:00, 1 month 25 days ago PUMA appoints Markus Neubrand as Chief Financial Officer PUMA appoints Markus Neubrand as Chief Financial Officer, effective October 1, 2024. Neubrand brings extensive finance and industry experience CFO Finance PUMA Industry Markus Neubrand
BRIEF published on 08/28/2024 at 12:05, 2 months 24 days ago PUMA Appoints Indrajeet Sen as SVP PUMA Group Sourcing Sustainability PUMA Leadership Indrajeet Sen Sourcing
PRESS RELEASE published on 08/28/2024 at 12:00, 2 months 24 days ago PUMA appoints Indrajeet Sen as SVP PUMA Group Sourcing PUMA appoints Indrajeet Sen as SVP PUMA Group Sourcing. Chief Sourcing Officer Anne-Laure Descours to step down in 2024 and become sustainability advisor. Changes in PUMA leadership team Sustainability Leadership Team PUMA Indrajeet Sen SVP
BRIEF published on 08/14/2024 at 09:35, 3 months 7 days ago PUMA Appoints Johan Kuhlo as Managing Director GCC PUMA Corporate Strategy Johan Kuhlo Managing Director GCC Middle East Market
PRESS RELEASE published on 08/14/2024 at 09:30, 3 months 7 days ago PUMA appoints Johan Kuhlo as Managing Director GCC PUMA appoints Johan Kuhlo as Managing Director GCC, realigns territories and management responsibilities to drive growth in the Middle East regions Middle East Managing Director Growth PUMA Johan Kuhlo
BRIEF published on 08/07/2024 at 08:05, 3 months 14 days ago PUMA Q2 Financial Results Align with Expectations Sales Growth Q2 Results Full-year Outlook Gross Profit Margin Operating Expenses
PRESS RELEASE published on 08/07/2024 at 08:00, 3 months 14 days ago PUMA delivers Q2 results fully in line with expectations PUMA delivers Q2 results fully in line with expectations, showing sales growth and improved profit margin amidst currency headwinds. CEO optimistic about future performance and strategic initiatives Sales Growth Strategic Initiatives PUMA Q2 Results Profit Margin
Published on 11/21/2024 at 13:30, 12 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 12 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 42 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 42 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 42 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 7 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 27 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 44 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 22 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 57 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 57 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
